Abstract
Most deaths in patients with acute myocardial infarction (AMI) have been due to severe arrhythmia and cardiogenic shock. While continuous electrocardiographic monitoring and drug treatment have significantly reduced mortality due to arrhythmia, cardiogenic shock still remains a major cause of death in patients with AMI.(1).
Supported by an International Fellowship from the Eli Lilly Co., Indianapolis, Indiana, and NIH grant #HE-11492
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson, R.: The relation between metabolic acidosis and cardiac arrhythmias in acute myocardial infarction. Am. Heart J. 76: 1, 1968.
Peretz, D.I., Scott, H.M., Duff, J., Dosseter, J.B., MacLean, L.D. and McGregor H.: The significance of lacticacidemia in the shock syndrome. Ann. New York Acad. Sci 119: 1133, 1965.
Sicuteri, F., Franchi, G., Del Bianco, P.L. and Del Bene, E.: A contribution to the interpretation of shock and pain in myocardial infarction. Malattie Cardiovasculari 8: 343, 1967.
Dzizinskii, A.A. and Kuimov, A.D.: Blood kinin system in pathogenesis and clinic of ischemic heart disease. Cor. Vasa 14: 9, 1972.
Glenn, T.M., Lefer, A.M., Martin, J.B., Lovett, W.L., Morris, J.N., and Wangensteen S.L.: Production of a myocardial depressant factor in cardiogenic shock, Am. Heart J. 82: 78, 1971.
Sicuteri, F., Antonini, F.M., Del Bianco, P.L., Franchi, G. and Curradi, C.: Prekallikrein and kallikrein inhibitor in plasma of patients affected by recent myocardial infarction. Advances in Experimental Medicine and Biology (eds. Back, N. and Sicuteri, F.) Vol. 21: p. 445 Plenum Press, N.Y. London 1972.
Kimura, E., Hashimoto, K., Furukawa, S. and Hayakawa, H.: Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am. Heart J. 85: 635, 1973.
Hashimoto, K., Furukawa, S., Hirose, M., and Hayakawa, H.: Changes in bradykinin level in coronary sinus blood after experimental coronary occlusion, and their relationships to hemodynamic changes. Singapore Med. J. 14: 356, 1973.
Hashimoto, K., Hamamoto, H., Tajima, N., and Kimura, E.: Changes in kinin system and hemodynamics in acute stage of myocardial infarction. A clinical study. VII World Congress of Cardiology, Buenos Aires, 1974.
Wilkens, H.J., and Steger, R.: in Screening Methods in Pharmacology, (eds. Turner, R.A. and Hebborn, P.) Vol. II p. 61 Academic Press Inc. 1971.
Wiegershausen, B., Hennighausen, G., Klausch, B., Korber, H.G. and Hauzeur, F.: Plasma kininogen level in myocardial infarction. Advances in Experimental Medicine and Biology (eds. F. Sicuteri, M. Rocha e Silva, & N. Back) Vol. 8 p. 221 Plenum Press, N.Y. 1970.
Reichgot, M.J., and Melmon, K.L.: Bradykinin and the cardiovascular system. Circulation 42: 563, 1970.
Altura, B.M., Hershey, S.G., and Altura B.T.: Microcirculatory actions of polypeptides and their use in the treatment of experimental shock, in Bradykinin and related kinins. Cardiovascular, biochemical and neutral actions. Advances in Experimental Medicine and Biology (eds. F. Sicuteri, M. Rocha e Silva, & N. Back) Vol. 8, New York, Plenum Press, p. 239, 1970.
Shionoya, S., Nakata, Y., Kamiya, K., Inagaki, A., and Yano, T. Influences of bradykinin on the microcirculation. Angiology 22: 456, 1971.
Webster, M.E. and Clark, W.R.: Significance of the callicreincallidinogen-callicun system in shock. Amer. J. Physiol.: 197: 406, 1959.
Brocklehurst, W.E. and Lahiri, S.C.: The production of bradykinin in anaphylaxis. J. Physiol. 160: 15, 1962.
Dawson, W., Starr, M.S. and West, G.B.: Inhibition of anaphylactic shock in the rat by antihistamines and ascorbic acid. Br. J. Pharmac. Chemother. 27: 249, 1966.
Back, N., Wilkens, H.J., and Steger, R.: Proteinases and proteinase inhibitors in experimental shock states. Ann. N.Y. Acad. Sci. 146: 691, 1968.
Stock, W. and Eigler, F.W.: Indirect evidence against a major role of kinins in tourniquet-shock by use of carboxypeptidase B. in Advances in Experimental Medicine and Biology (eds. Back, N. and Sicuteri, F.) Vol. 8 p. 355 Plenum Press, N.Y. 1970.
Urbanitz, D., Sailer, R., and Habermann, E.: In vivo investigations on the role of the kinin system in tissue injury and shock syndromes, in Advances in Experimental Medicine and Biology (eds. Back, N. and Sicuteri, F.) Vol. 8, p. 343, Plenum Press, N.Y. 1970.
Dzizinskii, A.A., and Kuimov, A.D.: Blood kinin system in pathogenesis and clinic of ischemic heart disease. Cor. Vasa 14: 9, 1972.
Pitt, B., Mason, J., Conti, C.R., and Colman, R.W.: Activation of the plasma kallikrein system during myocardial ischemia in Advances in Experimental Medicine and Biology (eds. Back, N. and Sicuteri, F.) Vol. 8, p. 403, Plenum Press, N.Y. 1970.
Raab, W.: Myocardial metabolism in the pathogenesis and treatment of angina pectoris. Cardiologia 22: 291, 1953.
Melmon, K.L., and Cline, M.J.: Kinins. Amer. J. Med. 43: 153, 1967.
Rocha e Silva, M.: Chemical Mediators of the acute inflammatory reaction. Ann. N.Y. Acad. Sci. 116: 899, 1964.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Hashimoto, K., Wanka, J., Kohn, R.N., Wilkens, H.J., Steger, R., Back, N. (1976). The Vasopeptide Kinin System in Acute Clinical Cardiac Diseases. In: Sicuteri, F., Back, N., Haberland, G.L. (eds) Kinins. Advances in Experimental Medicine and Biology, vol 70. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3267-1_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3267-1_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3269-5
Online ISBN: 978-1-4684-3267-1
eBook Packages: Springer Book Archive